Likely Diagnosis: Normal Post-Vaccination Reaction
This is almost certainly a normal inflammatory response to Shingrix vaccination, not a complication requiring medical intervention. The swelling at the injection site with pain radiating down the arm occurring 24 hours post-vaccination represents an expected "robust take" reaction that occurs in up to 16% of vaccinees and typically resolves spontaneously within 24-72 hours 1, 2.
Understanding the Clinical Picture
Key distinguishing features of normal reactions:
- Timing: Symptoms beginning within 24 hours post-vaccination are characteristic of normal inflammatory responses, not complications 3, 2
- Pain characteristics: Pain traveling down the arm suggests local inflammation affecting surrounding tissues, which is a recognized normal variant 2
- Expected frequency: Shingrix causes injection-site reactions (pain, redness, swelling) in the majority of recipients, with 9.5% experiencing grade 3 (severe) injection site reactions compared to 0.4% with placebo 3
- Systemic symptoms: Systemic symptoms occur in 11.4% of Shingrix recipients versus 2.4% in placebo recipients 3
What This Is NOT
This presentation does NOT suggest:
- SIRVA (Shoulder Injury Related to Vaccine Administration): While SIRVA can occur with improper injection technique causing subacromial-subdeltoid bursitis 4, the 24-hour timeframe and expected resolution pattern argue against this diagnosis
- Bacterial superinfection: Secondary infections are uncommon (0.55 per 10,000 vaccinees) and typically occur within 5 days or beyond 30 days, with progressively worsening symptoms rather than the expected improvement pattern 1, 2
- VITT (Vaccine-Induced Immune Thrombocytopenia and Thrombosis): This COVID-19 vaccine complication occurs 5-30 days post-vaccination, not within 24 hours 1
Management Algorithm
Immediate management (first 72 hours):
- Reassurance: Explain this is an expected reaction that will resolve spontaneously 2
- Supportive care only:
- What NOT to do:
Monitoring parameters:
- Expected course: Symptoms should peak at 8-10 days and improve within 24-72 hours without treatment 2
- Red flags requiring re-evaluation:
Important Clinical Caveats
This reaction does NOT contraindicate the second Shingrix dose:
- Mild to moderate local reactions are explicitly NOT contraindications to future vaccination 2
- The patient should receive the second dose 2-6 months after the first dose as scheduled 3
- Even extensive limb swelling (occurring in only 2% of patients) does not contraindicate future vaccination 2
True contraindications are limited to:
- History of anaphylactic or anaphylactic-like reactions to the vaccine or vaccine constituent 2
- Presence of moderate or severe illness with or without fever 2
Common pitfall to avoid:
- Do NOT confuse normal robust reactions (redness, swelling, warmth, pain >7.5 cm) with bacterial cellulitis—the key distinction is that normal reactions peak at days 8-10 and improve within 24-72 hours without progression, whereas bacterial infections progressively worsen unless treated 1, 2
When to Seek Urgent Medical Attention
Instruct the patient to return immediately if:
- Symptoms worsen progressively beyond 72 hours rather than improving 2
- Development of severe headache, unexplained bruising/bleeding, shortness of breath, or persistent abdominal pain (though these would suggest VITT, which occurs 5-30 days post-vaccination, not at 24 hours) 1
- Signs of true bacterial infection: increasing warmth, purulent drainage, or systemic toxicity 1, 2